|
|
Current Projects
- Nitrosamines and prostate cancer
- Serum insulin and glucose and prostate cancer
- Post-intervention follow-up of prostate cancer
- Cohort consortium study of prostate cancer risk, sex steroid hormone metabolism, and IGFs
- Weight, weight change, and BMI and prostate cancer
- Dietary carotenoids and retinol and prostate cancer
- Genes involved in insulin signaling/obesity and insulin resistance and chronic inflammation pathways with prostate cancer (& possibly gallbladder)
- Genetic variants in genes relevant to energy balance and prostate cancer
- C-reactive protein and prostate cancer
- Family history and prostate cancer
- Genetic polymorphisms in vitamin E transport/metabolism genes, vitamin E supplementation, and prostate cancer
- Genetic variants in inflammatory and respiratory burst pathway and prostate cancer risk
- Selenoprotein genetic polymorphisms in relation to prostate cancer risk
- Phytanic acid, genetic variation in branch-chain fatty acid oxidation pathways, and prostate cancer risk
- Adipokines and risk of prostate cancer
- Serum ß-carotene, a-tocopherol, and retinol and prostate cancer survival in the ATBC study
- The relationship between serum creatinine and prostate cancer
- Post-intervention follow-up of lung cancer
- P53 mutations (frequency, type, expression of the p53 protein) in lung cancer; Apoptosis and expression of bcl-2 and mcl-1 genes in lung cancer
- Screening of lung cancer with tumour markers in male smokers with negative chest radiography
- Biochemical measure of total antioxidant capacity and lung cancer
- Beta-carotene, lung cancer tissue study
- Telomere length and lung cancer
- Family history and lung cancer
- Lung cancer, smoking history and candidate genes for both
- Dietary patterns and lung cancer
- Serum chlamydia and lung cancer
- Mitocondrial DNA copy number and lung cancer
- Whole genome scans of lung cancer
- NOD2 SNPs and colon cancer
- Phenolic compounds in serum and the risk of colorectal cancer
- Polymorphism in metabolic genes (GSTs, NATs) and risk of colorectal cancer
- Serum and dietary vitamin E and risk of colon cancer
- Tooth loss and colorectal cancer
- One-carbon metabolism genetic variants in relation to colorectal cancer risk.
- Serum factors related to one-carbon metabolism and risk of colorectal cancer
- Pancreatitis polymorphisms and pancreatic cancer
- Insulin pathway polymorphisms and cox and inflammation and DNA repair & carcinogenic metabolism polymorphisms and pancreatic cancer
- BMI, adiponectin, c-peptide, CPR and (leptin) and pancreatic cancer
- Whole diet & pancreatic cancer
- Baseline serum carotenoids, retinol, alpha-tocopherol & pancreatic cancer
- Cox polymorphisms and pancreatic cancer
- Proteomics and pancreatic cancer
- Polymorphisms in folate, selenium and pancreatic cancer
- Telomere length and pancreatic cancer
- Whole genome scan pancreatic cancer in consortium
- Serum pepsinogen and pancreatic cancer
- Uracil misincorporation, global methylation, p53 strand breaks and pancreatic cancer
- Helicobacter species
- Markers of oxidative stress
- TGF-beta
- Methylation markers for risk prediction
- Plasma levels of advanced glycation end product and soluble receptor for advanced glycation end product and risk of pancreatic cancer
- Mitocondrial DNA copy number and pancreatic cancer
- Obesity and risk of pancreatic cancer in a pooled stydy of NCI-DCEG cohorts
- Aromatic amine hemoglobin adducts (from RBCs or whole blood) and serum PAH-albumin adducts and bladder cancer
- Whole genome scan of bladder cancer
- Serum pepsinogen and risk of gastric cardia and non-cardia cancers: A prospective study
- Serum ghrelin and gastric cancer
- Serum ferritin, transferrin, and CRP and gastric cancer
- Serum vitamin E and esophageal cancer in ATBC
- Serum factors related to one-carbon metabolism and risk of stomach and esophageal cancer
- Serum ghrelin and espophageal cancer
- Serum ferritin, transferrin, and CRP and esophageal cancer
- Serum IGF-1 and IGFBP-3 and renal cell cancer
- Dietary vitamin D and renal cell carcinoma
- Serum insulin and glucose and renal cell carcinoma
- Antioxidants, fruits and vegetables in relation to renal cell cancer
- BMI, hypertension, dietary intake, and renal cancer
- Vitamin D (serum and genetics) and renal cell carcinoma
- Serum factors related to one-carbon metabolism and risk of kidney cancer
- Heavy metal exposure and renal cell carcinoma
- Association of SNPs in genes in VHL-HIF Pathway and susceptibility of kidney cancer (iSelect)
- Flavonoid intake and the risk of renal cell carcinoma
- GWAS of kidney cancer
- Immunological markers and multiple myeloma (also including genetic polymorphisms)
- Physical activity and NHL
- Genetic variations in MTHFR, TYMS, SHMT1, MTR, and MTRR and risk of lymphoid cancers
- Serum indicators of folate, B12, B6, homocysteine and risk of lymphoid cancers
- Telomere length and hematopoietic cancer
- Serum vitamin D and lymphoma
- Serum IGF, insulin, glucose and lymphoma
- Genomic DNA methylation and lymphoma
- Mitocondrial DNA copy number and hematopoietic cancer
- Insulin, glucose and liver and biliary cancer
- Serum factors related to one-carbon metabolism and risk liver/biliary cancer
- Diet (antioxidants, fruits, vegetables) and laryngeal cancer
- HPV-16, HSV-1 and head and neck cancers
- Serum factors related to one-carbon metabolism and risk of oropharynx/larynx cancers
- Tooth loss and head and neck cancer
- Meat and fat intake and small bowel cancer
- Height and risk of cancer
- Genetic factors related to one-carbon metabolism and risk of other cancers (colorectal, stomach, kidney, liver, biliary, oropharynx, bladder, pancreas)
- Retrospective and prospective risk assessments for serum nutrients and cancer (lung, GI, prostate)
- Serum carotenoids and risk of cancers of the lung, prostate, bladder, colon, rectum, stomach
- Comparison of prospective and retrospective data in lung
- Toenail selenium concentration in relation to risk of prostate, colorectal, and other cancers
- Serum vitamin D and risk of several cancers (renal, pancreatic, lymphoma, stomach, esophagus, prostate, melanoma, larynx, liver/biliary, oropharynx, bladder, colorectal, lung, prostate)
- Tooth loss and all cancers in the ATBC study
- Carotenoids and total mortality
- Amyotrophic lateral sclerosis, intervention, dietary factors, and serum micronutrients
- Heavy metals and cardiovascular disease
- Effect of alpha-tocopherol and beta-carotene supplements on, and risk factors of diabetes
- Alcohol consumption, ADH3 polymorphisms, and all-cause mortality
- Dietary patterns and the risk of cardiovascular disease
- Glycemic index and the risk of cardiovascular disease
- Glycemic index and the risk of diabetes
- Intake of iron and iron status and the risk of coronary heart disease
- Effect of alpha-tocopherol and beta-carotene supplements on neurologic disorders (dementia, Parkinsons disease, and multiple sclerosis)
- Cross-sectional study of physical activity and biological markers (IGF-1, IGFBP-3, insulin, total testosterone, free testosterone, dihydrotestosterone, androstenedione, DHEAS, androstanediol glucuronide, estradiol, estrone, and SHBG)
- Determinants of serum alpha- and gamma-tocopherol levels
- Hazard analysis of smoking cessation relapse
- Hazard analysis of smoking abstinence
- Smoking cessation, medical and smoking history, and neurotransmitter variants
- Predictors of serum vitamin D
- Tooth loss and CHD death and total mortality
- CGEMS added value
- The joint modeling of smoking pattern and chronic disease
- GWAS marker predictors of micronutrient, anthropometric, and other biometric measures
|